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ABSTRACT
OBJECTIVE
To use the relation between cigarette consumption 
and cardiovascular disease to quantify the risk of 
coronary heart disease and stroke for light smoking 
(one to five cigarettes/day).
DESIGN
Systematic review and meta-analysis.
DATA SOURCES
Medline 1946 to May 2015, with manual searches of 
references.
ELIGIBILITY CRITERIA FOR SELECTING STUDIES
Prospective cohort studies with at least 50 events, 
reporting hazard ratios or relative risks (both hereafter 
referred to as relative risk) compared with never 
smokers or age specific incidence in relation to risk of 
coronary heart disease or stroke.
DATA EXTRACTION/SYNTHESIS
MOOSE guidelines were followed. For each study, 
the relative risk was estimated for smoking one, 
five, or 20 cigarettes per day by using regression 
modelling between risk and cigarette consumption. 
Relative risks were adjusted for at least age and often 
additional confounders. The main measure was the 
excess relative risk for smoking one cigarette per 
day (RR1_per_day−1) expressed as a proportion of that 
for smoking 20 cigarettes per day (RR20_per_day−1), 
expected to be about 5% assuming a linear relation 
between risk and consumption (as seen with 
lung cancer). The relative risks for one, five, and 
20 cigarettes per day were also pooled across all 
studies in a random effects meta-analysis. Separate 
analyses were done for each combination of sex and 
disorder.
RESULTS
The meta-analysis included 55 publications 
containing 141 cohort studies. Among men, the 
pooled relative risk for coronary heart disease was 
1.48 for smoking one cigarette per day and 2.04 for 20 
cigarettes per day, using all studies, but 1.74 and 2.27 
among studies in which the relative risk had been 
adjusted for multiple confounders. Among women, 
the pooled relative risks were 1.57 and 2.84 for one 
and 20 cigarettes per day (or 2.19 and 3.95 using 
relative risks adjusted for multiple factors). Men who 
smoked one cigarette per day had 46% of the excess 
relative risk for smoking 20 cigarettes per day (53% 
using relative risks adjusted for multiple factors), 
and women had 31% of the excess risk (38% using 
relative risks adjusted for multiple factors). For stroke, 
the pooled relative risks for men were 1.25 and 1.64 
for smoking one or 20 cigarettes per day (1.30 and 
1.56 using relative risks adjusted for multiple factors). 
In women, the pooled relative risks were 1.31 and 
2.16 for smoking one or 20 cigarettes per day (1.46 
and 2.42 using relative risks adjusted for multiple 
factors). The excess risk for stroke associated with one 
cigarette per day (in relation to 20 cigarettes per day) 
was 41% for men and 34% for women (or 64% and 
36% using relative risks adjusted for multiple factors). 
Relative risks were generally higher among women 
than men.
CONCLUSIONS
Smoking only about one cigarette per day carries 
a risk of developing coronary heart disease and 
stroke much greater than expected: around half 
that for people who smoke 20 per day. No safe 
level of smoking exists for cardiovascular disease. 
Smokers should aim to quit instead of cutting down 
to significantly reduce their risk of these two common 
major disorders.
Introduction
Around one billion adults worldwide smoke,1 with 
high prevalence in developing countries, where 49% 
of men and 11% of women use tobacco.2 Although the 
prevalence of current smokers has decreased over time 
in several countries, the global absolute number of 
smokers has increased owing to population growth.3 
Policies have successfully encouraged people to quit, 
using aids such as nicotine replacement therapy and 
electronic cigarettes (e-cigarettes).4
In the Health Survey for England (2013 and 2014), 
26% of current smokers reported that they wanted to 
cut consumption down but were not trying to stop, and 
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WhAT IS AlReAdy knoWn on ThIS TopIC
Smoking increases the risk of developing coronary heart disease and stroke
Many smokers believe that cutting down the number of cigarettes they smoke 
substantially reduces their risk of developing tobacco related disorders
Occasional individual studies and a meta-analysis of five studies in 1997 
reported that light cigarette smoking (less than five per day) is associated with a 
higher than expected risk of coronary heart disease
WhAT ThIS STudy AddS
Men who smoke about one cigarette per day have a 48% higher risk of heart 
disease than never smokers and a 25% higher risk of stroke (or 74% and 30%, 
respectively, when allowing for confounding factors)
The estimates are higher in women: 57% for heart disease and 31% for stroke 
(or 119% and 46% when allowing for multiple confounders), again compared 
with never smokers.
People who smoke about one cigarette each day have about 40-50% of the 
excess risk associated with smoking 20 per day (coronary heart disease and 
stroke)
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40-41% said that they smoked less than in the previous 
year.5 The percentage of smokers who consume one 
to five cigarettes per day has steadily risen (from 
18.2% to 23.6% between 2009 and 20145), with a 
similar pattern in the US, where the proportion of 
smokers who consume less than 10 cigarettes per day 
increased from 16% to 27% between 2005 and 2014.6 
A recent Cochrane review discussed the evidence for 
ways of helping smokers who wish to reduce their 
consumption.7
Smoking few cigarettes is generally believed to 
be relatively safe, as has been incorrectly assumed 
for light/low nicotine cigarettes.8 Among 24 658 US 
adolescents, 10% thought that light smoking was not 
harmful, and only 35% of light smokers considered 
their habits to be associated with “a lot of harm.”9 
Reducing consumption might be expected to reduce 
harm in a proportionate way—that is, that smoking 
one instead of 20 cigarettes per day has about one 
twentieth (5%) of the risk. This seems to be the case 
for lung cancer, for which the large American Cancer 
Society Prevention Study II showed an approximately 
linear relation between risk of lung cancer and number 
of cigarettes smoked per day, but the dose-response 
for cardiovascular disease is steep at low consumption 
and then levels off,10 consistent with the shape 
reported previously.11
In a seminal systematic review of second-hand 
smoke and coronary heart disease among never 
smokers published in the BMJ 20 years ago, Law and 
colleagues drew attention to the 1.30 risk ratio being 
relatively large compared with the 2-3 typically seen 
in studies of active smokers.12 Their conclusions on 
second-hand smoke were supported by a meta-analysis 
of active cigarette smoking and risk of coronary heart 
disease from five cohort studies, in which the modelled 
relative risk for smoking one cigarette per day (1.39) 
was consistent with that for exposure to second-hand 
smoke.
Although the non-linear relation between coronary 
heart disease and low cigarette consumption has 
been reported before (individual studies, as well as 
official reports from the US Surgeon General), it still 
is still not commonly known by the general public or 
health professionals, particularly those not involved 
in tobacco and health. We thus aimed to extend the 
previous work on coronary heart disease,12 by using a 
systematic review to provide a major body of evidence. 
We also aimed to show that a similar non-linear relation 
exists between stroke and low cigarette consumption.
Methods
Data sources and searches
We did a systematic literature review of English 
language articles published between 1946 and May 
2015 in Medline (MOOSE guidelines13) that reported 
the association between cigarette consumption and 
coronary heart disease and stroke. Supplementary 
figure A shows the search terms and flowchart: 13 861 
abstracts were reviewed (by DM and SB), and any 
selected for consideration had their reference list 
manually checked for additional studies. Several study 
reports were based on combining data from at least two 
separately conducted cohort studies.
Study selection and data extraction
We included prospective cohorts with at least 50 
cardiovascular disease events (mortality, morbidity, 
or both) to minimise the potential for reporting bias, 
in which large but unreliable effects might be seen in 
small studies. Reports had to give hazard ratios from 
a Cox proportional hazards regression or relative risks 
based on incidence/mortality, which must have been 
adjusted by at least age, or incidence reported in age 
groups. Results had to be available in at least three 
smoking categories, not including the reference group 
of never smokers. The populations of the cohorts had 
to be generally healthy; we excluded studies based 
only on people at high risk (for example, taking drugs 
for cardiac related disorders). Results had to be given 
separately for men and women, or, if they were based 
on both combined, the hazard ratios must be adjusted 
for age and sex. We excluded six studies spuriously 
showing that the hazard ratio or relative risk 
decreased with increasing consumption (justification 
in supplementary figure A). Study characteristics 
extracted were country, time period, sex, smoking 
categories, incidence, hazard ratio or relative risk, 
number of participants, number of events, and 
confounding factors adjusted for. In the few instances 
in which only age adjusted incidence/mortality results 
were available, we calculated the relative risk in each 
smoking category. Most studies reported hazard ratios, 
and we always used hazard ratios adjusted for multiple 
factors when provided (supplementary table A); 30 
of the 55 publications made allowance for multiple 
(at least two) factors in addition to age and sex when 
providing hazard ratios. We extracted hazard ratios 
and relative risks separately for coronary heart disease, 
stroke, or cardiovascular disease (coronary heart 
disease and stroke combined).
Statistical methods
Hereafter, we refer to hazard ratio or relative risk as 
relative risk (consistent with many studies included). 
Instead of modelling risk with consumption for 
each study (which is non-linear), we modelled the 
logarithm of risk, using similar methods as before.12 
14 This involved fitting a log-linear variance weighted 
regression model between incidence or relative risk 
and cigarette consumption (using all reported smoking 
categories in the publications). Although this approach 
makes the relation more linear (when examined on a 
log scale), it might still underestimate the increase in 
risk at very low consumption levels.
We obtained a regression model for each study 
report separately (Stata software). For consumption, 
we used the midpoint of the reported number of 
cigarettes per day—for example, three cigarettes per 
day if the category was one to five cigarettes per day—
which we then adjusted for carboxyhaemoglobin 
and cotinine because this allows for lower inhalation 
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with increasing cigarette consumption as previously 
established.14 For studies that reported relative risks 
adjusted for age (or for additional factors), the model 
contained the logarithm of the relative risk (dependent 
variable) and consumption (independent variable) 
using only the midpoint of the cigarettes per day 
categories. For studies that reported incidence in each 
age category, we fitted log-linear model that contained 
incidence (dependent variable) and consumption 
(independent variable) with age as a covariate 
(median age in each age category), and we estimated 
the relative risk by using an interaction term between 
age and consumption. This provided estimates in 
each age category (45, 55, and 65 years) because the 
risk of cardiovascular disease changes with age.15 
The reference value of 1.0 (never smokers) was not 
included in the regression to avoid forcing the model 
through the origin and unduly affecting the dose-
response relation (also because we were ultimately 
interested only in comparing between high and low 
consumption). We used the standard error of the 
logarithm of the relative risk, or the number of events 
if the standard error was unavailable, as weights in 
the regression; if both were unavailable, we did an 
unweighted log-linear regression for the study. The 
reference group was lifelong never smokers, although 
in seven reports it was unclear whether former smokers 
might have been included.
The main quantitative measure was the percentage 
change in risk (excess relative risk) associated with 
smoking one (or five) cigarette(s) per day, expressed 
as a proportion of the percentage change for smoking 
20 cigarettes per day. For example, if the relative risks 
were 1.4 and 1.9 for smoking one and 20 cigarettes 
per day, respectively, the proportion of excess relative 
risk associated with one cigarette per day is 44%: 
(1.4−1)/(1.9−1)×100. One or five cigarettes per day 
reflect typical levels of low consumption. We did three 
different types of analyses, to check for consistency. 
Firstly, from each regression analysis for each study, we 
used the model to estimate the relative risk for smoking 
one cigarette per day compared with never smokers, 
and also for smoking five and 20 cigarettes per day. We 
then calculated the excess relative risks for one and 
five cigarettes per day (compared with 20) and took the 
median value of each of these across studies. We did 
multiple separate analyses according to combinations 
of sex and disease type (“within study” analyses). 
Secondly, we obtained a single regression model across 
all studies (again done separately for each combination 
of sex and disorder) by using the individual cigarettes 
per day values and reported relative risk estimates 
(log scale) in a random effects meta-regression (SAS 
Proc Mixed). We then used the pooled coefficients to 
estimate the relative risk for one, five, and 20 cigarettes 
per day (another “within study” analysis). We also 
used these regressions to examine whether a quadratic 
trend might be better than a linear trend but found 
no evidence of this (the quadratic coefficients were 
negligible and not statistically significant). Thirdly, 
from the log-linear regression model in each study, we 
estimated the relative risk for smoking one cigarette 
per day and then combined these across studies in a 
random effects meta-analysis, fitted separately for each 
disease group and sex, using RevMan; we repeated 
this for smoking five and 20 cigarettes per day. These 
results (and corresponding diagrams) indicate the 
variability in relative risk in each smoking group across 
studies, but they do not directly reflect the within study 
correlation between risk and consumption (as in the 
first and second analyses above).
The results are examined in relation to assuming 
that smoking one cigarette per day is associated with 
about 5% of the excess relative risk when smoking 20 
cigarettes per day. Our regressions used a logarithmic 
scale, so smoking one cigarette per day would actually 
have 3.5% or 5.5% of the excess risk if the relative risk 
for 20 cigarettes per day was 2.0 or 3.0, respectively, 
values typically seen in the studies (log(relative risk 
for 20 cigarettes per day)=20×log(relative risk for one 
cigarette per day)).
Patient involvement
No patients were involved in setting the research 
question or the outcome measures, nor were 
they involved in developing plans for design or 
implementation of the study. No patients were asked to 
advise on interpretation or writing up of results. There 
are no plans to disseminate the results of the research to 
study participants or the relevant patient community. 
We did not evaluated whether the studies included in 
the meta-analysis had any patient involvement.
Results
The meta-analyses were based on 141 separately 
conducted cohort studies contained in 55 study reports 
(several involved the pooling of multiple studies),16-70 
and two other study reports are referred to later on.71 72 
Table 1 shows all summary results.
Coronary heart disease
The pooled relative risk from 26 study reports was 1.48 
(95% confidence interval 1.30 to 1.69) for men who 
smoked, on average, one cigarette per day and 1.58 
(1.39 to 1.80) for those who smoked five cigarettes 
per day; the relative risk for smoking 20 cigarettes 
per day was 2.04 (1.86 to 2.24) (fig 1; supplementary 
figure B). (Excluding three studies that might have 
included former smokers in the reference group 
increased the relative risks for one and 20 cigarettes 
per day to 1.53 and 2.09, as expected.) Figure 2 
shows the distribution of the excess relative risks; 
most had values of at least 25%. Using within study 
comparisons, smoking one cigarette per day had 46% 
(interquartile range 24-56%) of the excess relative 
risk for that when smoking 20 cigarettes per day, and 
the corresponding estimate for five cigarettes per day 
was 57% (36-64%).
The 18 reports of women showed that one cigarette 
per day had 31% (interquartile range 2-46%) of the 
excess risk of 20 cigarettes per day (pooled relative 
risks 1.57 v 2.84), and smoking five cigarettes per 
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day had 43% (14-55%) the excess risk (relative risk 
1.76) (fig 3; supplementary figure C. (Excluding one 
study that might have included former smokers in the 
reference group increased the relative risks for one and 
20 cigarettes per day to 1.63 and 2.87.)
All of these estimates were similar to those obtained 
from the meta-regression (using a single model across 
studies) (table 1). Also, the relative risk estimates for 
one, five, and 20 cigarettes per day were mostly similar 
when produced by pooling these separately across 
studies (not within study analysis) to those from the 
meta-regressions (within study analysis).
There was a suggestion that the relative risks at low 
consumption might be higher for women than for men 
(1.57 v 1.48 for one cigarette per day; 1.76 v 1.58 for 
five cigarettes per day), consistent with a higher risk of 
coronary heart disease in women reported by others.73 
A comparison between sexes could also be examined 
directly within the same study cohort, where a higher 
relative risk was seen, without modelling: Hirayama et 
al (relative risk 1.61 for women versus 1.50 for men, 
for smoking one to four cigarettes per day),29 Nilsson et 
al (1.47 v 1.24, for smoking one to seven cigarettes per 
day),53 Prescott et al (2.14 v 1.03, for smoking three 
to five cigarettes per day),72 and Bjartveit et al (2.94 v 
2.74, for smoking one to four cigarettes per day).17
Supplementary figure D shows the forest plots for 
the age and sex adjusted relative risks in five studies 
for which results were not reported separately by sex: 
consuming one or five cigarettes per day had 53% or 
61% of the excess risk, compared with 20 cigarettes 
per day (table 1). Supplementary figures E and F are 
the forest plots for coronary heart disease and smoking 
consumption in men and women separately for people 
aged 45, 55, and 65 years. The individual relative 
risks among men reflect the decreasing strength of 
association between coronary heart disease and 
smoking as people get older. The excess risk for smoking 
one cigarette per day expressed as a percentage of that 
for 20 cigarettes per day remained high throughout 
(fig  2): 35%, 33%, and 20% for a man aged 45, 55, 
and 65 years, respectively; the corresponding figures 
for women were 11%, 15%, and 36% (in which the 
older age group seems to have a larger estimate, but 
Table 1 | Relative risk of cardiovascular disease for smoking one, five, or 20 cigarettes per day (CPD): summary results from meta-analyses
Cohort
No of  
study  
reports
Approximate  
No of  
participants
Approximate  
No of events
Pooled relative risk (95% CI) for smoking (compared with  
never smokers)*
Excess relative risk, as % of that  
for 20 CPD†
1 CPD 5 CPD 20 CPD 1 CPD 5 CPD
Coronary heart disease
Men 26 2.31 million 57 152 1.48 (1.30 to 1.69); 
(1.45)‡
1.58 (1.39 to 1.80); 
(1.56)‡
2.04 (1.86 to 2.24); 
(2.06)‡
46; (46)*; (42)‡ 57; (56)*; (53)‡
Women 18 2.34 million 29 870 1.57 (1.29 to 1.91); 
(1.59)‡
1.76 (1.46 to 2.13); 
(1.79)‡
2.84 (2.21 to 3.64); 
(2.81)‡
31; (31)*; (33)‡ 43; (41)*; (44)
Combined 5 1.01 million 15 153 1.65 (1.53 to 1.78); 
(1.67)‡
1.72 (1.62 to 1.83); 
(1.81)‡
2.34 (1.96 to 2.79); 
(2.44)‡
53; (49)*; (47)‡ 61; (54)*; (56)‡
Men aged:
 45 years 8 938 000 27 697 1.65 (1.26 to 2.16) 1.81 (1.40 to 2.33) 2.72 (2.16 to 3.43) 35 46
 55 years 8 1.41 (1.17 to 1.70) 1.51 (1.27 to 1.80) 2.03 (1.74 to 2.36) 33 44
 65 years 8 1.17 (0.96 to 1.43) 1.24 (1.03 to 1.48) 1.49 (1.28 to 1.74) 20 36
Women aged:
 45 years 3 555 000 14 665 1.26 (0.98 to 1.62) 1.34 (0.92 to 1.96) 2.19 (1.11 to 4.32) 11 26
 55 years 3 1.21 (1.05 to 1.39) 1.26 (0.98 to 1.62) 1.77 (1.00 to 3.11) 15 28
 65 years 3 1.15 (1.06 to 1.25) 1.24 (1.11 to 1.40) 1.47 (0.94 to 2.29) 36 45
Stroke
Men 17 3.40 million 71 173 1.25 (1.13 to 1.38); 
(1.37)‡
1.30 (1.18 to 1.43); 
(1.42)‡
1.64 (1.48 to 1.82); 
(1.62)‡
41; (39)*; (60)‡ 52; (47)*; (68)‡
Women 10 3.59 million 60 520 1.31 (1.13 to 1.52); 
(1.35)‡
1.44 (1.22 to 1.70); 
(1.48)‡
2.16 (1.69 to 2.75); 
(2.13)‡
34; (27)*; (31)‡ 44; (38); (42)‡
Combined 2 228 000 2874 1.52 (1.10 to 2.10); 
(1.56)‡
1.63 (1.19 to 2.21); 
(1.65)‡
1.90 (1.54 to 2.35); 
(2.03)‡
58; (58)*; (54)‡ 66; (70)*; (63)‡
Men aged:
 45 years 2 315 000 4456 1.41 (1.03 to 1.94) 1.62 (1.26 to 2.09) 2.89 (2.31 to 3.62) 22 35
 55 years 2 1.27 (1.02 to 1.57) 1.39 (1.09 to 1.75) 2.01 (1.46 to 2.76) 25 43
 65 years 2 1.18 (0.90 to 1.54) 1.21 (0.89 to 1.64) 1.44 (0.96 to 2.15) 15 30
Women aged:
 45 years 1 534 000 5512 1.40 (0.93 to 2.11) 1.60 (1.14 to 2.24) 2.64 (2.20 to 3.17) 24 37
 55 years 1 1.25 (0.95 to 1.64) 1.41 (1.13 to 1.76) 2.22 (1.97 to 2.51) 20 34
 65 years 1 1.12 (0.85 to 1.47) 1.25 (1.00 to 1.56) 1.87 (1.66 to 2.11) 14 29
Cardiovascular disease (coronary heart disease and stroke not reported separately)
Men 7 111 000 3480 1.45 (1.00 to 2.11); 
(1.61)‡
1.59 (1.11 to 2.26); 
(1.70)‡
2.19 (1.56 to 3.09); 
(2.10)‡
20; (38)*; (55)‡ 34; (50)*; (64)‡
Women 1 153 000 2768 1.65 (1.13 to 2.40) 1.74 (1.30 to 2.34) 2.16 (1.69 to 2.76) 56; (56)* 64; (64)*
Combined 4 1.00 million 36 525 1.63 (1.53 to 1.73); 
(1.64)‡
1.71 (1.63 to 1.80); 
(1.75)‡
2.27 (1.96 to 2.62); 
(2.25)‡
50; (50); (51)‡ 60; (56)*; (60)‡
*From combining relative risk for one CPD across all studies (and again, separately, for five and 20 CPD). Although they do not reflect within study correlations, in most cases they are close to 
those obtained from fig 2 and also meta-regressions (both of which are based on within study analyses).
†From within study analyses (fig 2); they represent median values across studies.
‡Estimates obtained from single meta-regression model across all studies (for men and women separately and for each disorder).
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there were only three studies here). Table 1 shows the 
results for five cigarettes per day.
All estimates (men, women, and both together) are 
much higher than the expected 5% had a linear or log-
linear relation existed between consumption and risk.
Stroke
Figure 4 and supplementary figures G and H show 
the relative risks for stroke. Among men who smoked 
one cigarette per day, the relative risk was 1.25 (1.13 
to 1.38); for women, it was 1.31 (1.13 to 1.52). The 
corresponding estimates for smoking 20 cigarettes per 
day were 1.64 (1.48 to 1.82) and 2.16 (1.69 to 2.75). 
These are again consistent with a slightly larger effect 
of smoking in women at the lowest smoking levels but 
more so at higher consumption, compared with men 
(1.44 v 1.30 for five cigarettes per day; 2.16 v 1.64 for 
20 cigarettes per day), as seen elsewhere.73
From the within study analyses (fig 2), the 
distribution of excess relative risks again showed that 
most exceeded 25%. Smoking one cigarette per day had 
an estimated 41% (interquartile range −7-62%) of the 
excess relative risk of men who smoked 20 cigarettes 
per day (from 17 studies), and the corresponding figure 
for five cigarettes per day was 52% (9-70%). These 
were similar to the findings in women (10 studies), in 
whom one cigarette per day had 34% (3-51%) of the 
excess risk of 20 cigarettes per day and five cigarettes 
per day had 44% (16-60%).
Supplementary figure I shows the forest plots for 
the age and sex adjusted relative risks. Supplementary 
figure J shows the forest plots for stroke and cigarette 
consumption in men according to age. The excess 
risk for smoking one cigarette per day expressed as a 
percentage of that for 20 cigarettes per day was 22%, 
25%, and 15% for a man aged 45, 55, and 65 years 
(two studies); the corresponding figures for women 
were 24%, 20%, and 14% (although these were based 
on only one study).
As with coronary heart disease, all estimates for 
stroke (men, women, and both together) were much 
higher than the 5% value expected with a linear or log-
linear relation.
All cardiovascular disease
Supplementary figures K and L are forest plots for 
cardiovascular disease (coronary heart disease and 
stroke reported together), showing adjusted relative 
risks in men or women. Again, results were consistent 
with those seen for each disorder separately.
Heterogeneity and bias
The heterogeneity seen in some meta-analyses is largely 
due to statistically significant relative risk estimates 
that differ from each other, and several reasons for this 
may exist (for example, with or without adjustment for 
multiple confounders). In figure 1, 15 estimates for one 
cigarette per day were each statistically significant, 
ranging between 1.19 and 2.48. However, even the 
lowest relative risk of 1.19 is a significant increase in 
risk of coronary heart disease (representing 25% of the 
excess risk compared with its corresponding estimate 
for 20 cigarettes per day: relative risk=1.77).
We explored the possibility that some heavy smokers 
reduced to light smoking during the course of the 
study, which in turn might substantially reduce the 
relative risks in the high consumption categories, 
moving them closer to that for light smokers, when 
using baseline consumption to produce relative risks. 
This could overestimate the excess relative risk for one 
to five cigarettes per day when compared with that for 
20 cigarettes per day. Such changes in smoking habits 
are expected to have largely occurred in the later 
years, so we examined only studies that had follow-up 
to 1995, to see whether the relative risks were much 
higher than those based on all studies. This was not 
the case. The pooled relative risks for coronary heart 
disease associated with smoking 20 cigarettes per day 
were 1.8 (1.6 to 2.0) for men and 2.5 (2.0 to 3.1) for 
women, a modest reduction compared with 2.0 and 2.8 
from all studies in table 1. Also, we found no evidence 
of a negative trend between size of relative risk for 
smoking 20 cigarettes per day and last calendar year of 
follow-up (which might suggest many heavy smokers 
cutting down, and whether this increases over time): 
Spearman’s correlations were positive: 0.30 (P=0.15) 
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Fig 1 | Relative risk for coronary heart disease for men smoking one cigarette per day. 
IV=inverse variance. Studies are in reference numbers 16-70. Excluding five studies 
that used relative risks instead of hazard ratios increased pooled relative risk (to 1.53)
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for men and 0.33 (P=0.20) for women (coronary heart 
disease studies).
Three large studies (from different countries: 
Denmark, Norway, and South Korea) specifically 
examined the effect of reduced smoking on risk of 
cardiovascular disease. In one study (19 423 adults), 
only 7.2% of “heavy” smokers (at least 15 cigarettes 
per day) reduced their consumption by at least 50% 
but continued to smoke when assessed five to 10 
years after baseline (verified by carbon monoxide 
or cotinine concentrations). There was no clear risk 
reduction for coronary heart disease compared with 
continuing heavy smokers after 14 years’ follow-up 
(adjusted relative risk 1.06), in contrast to a relative 
risk of 0.67 for quitters.74 However, a large reduction in 
risk of lung cancer was seen in the group who reduced 
consumption (relative risk 0.44).75 In the second study 
(51 210 adults), 4.2% of heavy smokers (at least 15 
cigarettes per day) reduced their consumption by at 
least 50% but continued to smoke when recorded three 
to 13 years after baseline. The adjusted relative risk 
for cardiovascular disease after 21 years’ follow-up 
was 1.02 (compared with continuing heavy smokers), 
unlike the benefit seen in quitters (relative risk 0.46) 
or the positive effect on risk of lung cancer in those 
who reduced (relative risk 0.66).76 In the third study 
(475 734 adults), 5.2% of heavy smokers (at least 20 
cigarettes per day) reduced to less than 10 cigarettes 
per day two years later, with little risk reduction after 
nine years’ follow-up (adjusted relative risk 0.85 for 
stroke and 0.92 for coronary heart disease, compared 
with continuing heavy smokers), in contrast to the 
beneficial effect in quitters (relative risk 0.70 for 
stroke and 0.43 for coronary heart disease)77 and the 
effect on lung cancer in those who reduced (relative 
risk 0.66).78 These studies indicate that a substantial 
bias is unlikely to be produced by heavy smokers 
cutting down, because only a small proportion did 
so, and that those who reduced consumption did not 
seem to have much benefit in terms of cardiovascular 
disease risk.
Model reliability
We checked the reliability of the regression models 
by comparing the estimated relative risks for smoking 
one, five, and 20 cigarettes per day with those seen 
in several individual studies that reported results 
specifically for low consumption (one to seven 
cigarettes per day). Our modelled estimates were close 
to those observed (supplementary table B). A high 
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Fig 2 | Distribution of excess relative risk for smoking one or five cigarettes per day, each in relation to smoking 20 
per day, using within study results (horizontal dashes show median). For example, in Lawlor et al (2008),48 estimated 
relative risk for coronary heart disease (CHD) was 1.83 or 2.63 for those smoking one or 20 per day, respectively (from 
regression analysis of this study). Proportion of excess relative risk associated with one cigarette per day is therefore 
51%: (1.83−1)/(2.63−1), which is plotted. (A negative value is when relative risk for one (or five) per day is <1.0.) For 
CHD in men, one study (Wen et al 2004)66 reported decreasing relative risks for increasing consumption for ≥65 age 
group, which appears as excess relative risk percentage of >100% (for completeness these are kept in, but do not 
affect median value)
RESEARCH
the bmj | BMJ 2018;360:j3984 | doi: 10.1136/bmj.j3984 7
excess relative risk (in comparison with 20 cigarettes 
per day) was seen in 17 of 20 estimates (median 57% 
all estimates; 49% for coronary heart disease and 
62% for stroke, comparable to those from the meta-
analyses). Supplementary figure M shows examples of 
individual studies of coronary heart disease or stroke, 
plotting the observed (reported) relative risks with the 
ones we estimated using the log-linear model; the fit 
was generally good.
Confounding
We explored the influence of confounding factors by 
doing meta-analyses according to whether studies 
made allowance for three or more factors (which 
in addition to age included cholesterol for studies 
of coronary heart disease and cholesterol or blood 
pressure for studies of stroke) (table 2). One study 
did not adjust for either cholesterol or blood pressure 
but made allowance for multiple other confounders, 
so we also included it with the “adjusted” group.55 
Additional factors often included body mass index, 
education, history of diabetes, and physical activity 
(see supplementary table A).
Among men, 11 studies of coronary heart disease 
had multivariable adjusted relative risks, 17 22 32 36 46-48 58 
60 67 70 and the pooled relative risks were 1.74 and 2.27 
for smoking one and 20 cigarettes per day (table  2). 
From the meta-regressions, one cigarette per day has 
53% of the excess relative risk of 20 cigarettes per day. 
These adjusted relative risks were higher than those 
obtained from the 15 other studies that did not allow 
for multiple confounders: 1.36 and 1.89 for one and 
20 cigarettes per day, and the excess relative risk for 
one cigarette per day is 36% (lower than the estimate 
when we used adjusted relative risks). Among women 
(nine studies),17 32 36 39 47 55 58 67 70 the pooled adjusted 
relative risks were 2.19 and 3.95 for one and 20 
cigarettes per day; and one cigarette per day represents 
38% of the excess relative risk for 20 cigarettes per 
day. The pooled relative risks for the other nine studies 
that did not allow for multiple confounders were 1.26 
and 2.11 for one and 20 cigarettes per day, and the 
excess relative risk for one cigarette per day was 25% 
(again, lower than the estimate when we used adjusted 
relative risks).
Among men, there were six studies of stroke,28 40 
42 48 51 60 and the pooled adjusted relative risks were 
1.30 and 1.56 for smoking one and 20 cigarettes per 
day, with one cigarette per day representing 64% of 
the excess relative risk for 20 cigarettes per day. In 
the other 11 studies that did not allow for multiple 
confounders, the pooled relative risks were 1.20 
and 1.68 for one and 20 cigarettes per day, and one 
cigarette per day had 38% of the excess relative risk for 
20 cigarettes per day. Among women (five studies),28 38 
40 47 55 the relative risks for stroke were 1.46 and 2.42 
for one and 20 cigarettes per day, and one cigarette per 
day had 36% of the excess relative risk for 20 cigarettes 
per day. In the other five studies without multiple 
adjustment, the relative risks were 1.15 and 1.94 (15% 
of the excess relative risk).
All of the studies that reported results for men 
and women combined had relative risks adjusted for 
multiple confounders. Estimates of excess relative 
risk associated with one cigarette per day were 47% 
(coronary heart disease), 54% (stroke), and 51% 
(cardiovascular disease), from the meta-regressions 
in table 1. As with previous analyses, the adjusted 
relative risks among women for smoking one 
cigarette per day were higher than for men (2.19 v 
1.74 for coronary heart disease and 1.46 v 1.30 for 
stroke) (table 2).
Study quality
Study quality is difficult to assess, particularly when 
examining old studies, because “positive” design 
attributes were often not reported in publications. Our 
aim was not to examine a new association between a 
risk factor and a disorder but rather to use a feature 
of an already established causal relation, so the 
question of study quality is not so relevant. However, 
the variability in different observational study designs 
is the reason why we focused only on prospective 
cohort studies. Nevertheless, we examined study 
quality with the Newcastle-Ottawa assessment scale 
for cohort studies,79 using the largest set (that is, the 
26 studies of coronary heart disease in men). Of these, 
we considered 15 to be “good quality,” and the pooled 
relative risk for smoking one cigarette per day was 1.62 
(1.45 to 1.82), higher than that based on all studies 
(relative risk 1.48); our interest was in whether it 
would be substantially lower.
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Fig 3 | Relative risk for coronary heart disease for women smoking one cigarette per 
day. IV=inverse variance. Studies are in reference numbers 16-70. Excluding two 
studies that used relative risks instead of hazard ratios slightly increased pooled 
relative risks (to 1.63).
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discussion
We have shown that a large proportion of the risk 
of coronary heart disease and stroke comes from 
smoking only a few cigarettes. This has important 
consequences for smokers who believe that light 
smoking carries little or no harm. Our estimates 
for people who smoke one or five cigarettes per day 
represent light smoking, given that the daily habits 
of such smokers typically vary between one and five 
cigarettes per day. We have also indicated that the 
relative risk for smoking either one or five cigarettes 
per day seemed to be higher among women than men. 
Smoking one cigarette per day carries around 40-
50% of the excess risk for developing coronary heart 
disease and stroke of smoking 20 cigarettes per day, 
and smoking five cigarettes per day has around 55-
65% of the excess risk (particularly when we focused 
on studies that reported relative risks adjusted for 
multiple confounders).
The high relative risk associated with low smoking 
levels is seen clearly in individual cohort studies 
(supplementary table B). For example, in one study 
(42 722 people), the relative risk for coronary heart 
disease among men was 2.74 (one to four cigarettes per 
day), representing 63% of the excess relative risk for 
smoking 20-24 cigarettes per day (relative risk 3.75).17 
This contrasts with the effects observed for lung cancer 
in the same study, with relative risks of 2.79 versus 
31.69,17 representing 6% of the excess relative risk, 
consistent with a linear relation between cigarette 
consumption and risk—that is, 5% of the consumption 
associated with about 5% of the excess risk, which has 
also been shown in other large studies.10 55 A recent 
study (290 215 US adults) showed that consistent light 
smoking throughout a lifetime also has a large excess 
risk for cardiovascular disease mortality: hazard ratio 
2.78 for smoking less than one cigarette per day and 
1.50 for one to 10 cigarettes per day, compared with 
2.77 and 3.16 for smoking 21-30 and more than 30 
cigarettes per day, respectively.80
We have also confirmed that low cigarette 
consumption is associated with a high risk of stroke. 
This evidence is further supported by studies of second-
hand smoke in never smokers,81-84 in the same way as 
for coronary heart disease.12 83 In a meta-analysis of 
seven studies of never-smokers,82 the relative risks 
for developing stroke associated with second-hand 
smoke, compared with unexposed never smokers, 
were 1.35 (95% confidence interval 1.22 to 1.50) in 
all participants, 1.40 (1.09 to 1.81) among men, and 
1.43 (1.28 to 1.61) among women, consistent with our 
results for actively smoking one cigarette per day.
Potential confounding is worth considering. Different 
studies adjusted for different factors, but always for at 
least age and sex (when men and women were analysed 
together), which are two important confounders for 
cardiovascular disease. However, heavy smokers tend 
to have more adverse cardiovascular risk factors than 
light smokers (such as higher body mass index and 
central adiposity and poorer diet).85-87 Therefore, light 
smokers should have characteristics that are more 
protective against cardiovascular disease, compared 
with heavier smokers. Adjusting for these other risk 
factors should attenuate differences in cardiovascular 
disease risk between light and heavy smokers, not 
dilute them, such that when these factors are allowed 
for the estimates of excess risk for one or five cigarettes 
per day, in relation to 20, should be even larger than 
when based on all studies together. This is what we 
found when focusing only on studies that had adjusted 
for multiple confounding factors (table 2).
The relative risks for coronary heart disease and 
stroke in our analyses are in line with that for all 
current smokers reported by Thun et al 2013 using 
several cohort studies,62 and they also suggest that the 
association between smoking and these disorders has 
got stronger over time. For coronary heart disease, an 
earlier estimate of relative risk was 1.78 among men 
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Fig 4 | Relative risk for stroke for smoking one cigarette per day in men (top) and women 
(bottom). Studies are in reference numbers 16-70. IV=inverse variance. Excluding four 
studies in men and one study in women that used relative risks instead of hazard ratios 
slightly increased pooled relative risks to 1.28 for men and 1.34 for women
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compared with 2.50 in more recent cohort studies, 
with similar figures for women (2.0 previously and 
now 2.86). However, some of this effect could be due 
to decreasing exposure to second-hand smoke in the 
reference group (never smokers) after the introduction 
of smoke-free legislation. If the effect is becoming 
stronger, the relative risk for light smokers could now 
be even higher than we report, with a potentially 
greater percentage of excess risk in relation to heavier 
smokers. Although we had only summary data (hence 
limited ability to show trends reliably), we saw some 
suggestion of a positive trend between the size of the 
relative risk for smoking one cigarette per day and 
the last calendar year of follow-up for each study: 
Spearman’s correlation 0.51 (P=0.008) for men and 
0.21 (P=0.42) for women when we used studies of 
coronary heart disease, and 0.23 (P=0.39) and 0.56 
(P=0.11) among men and women for studies of stroke.
Owing to the large effect of tobacco smoke at low 
doses, exposure to second-hand smoke in the reference 
group (never smokers) might lead to underestimation 
of the relative risk for one and 20 cigarettes per day 
and consequently dilute the percentage effect of one 
compared with 20 cigarettes per day. The extent of this 
depends on the degree of contamination (particularly 
for women who have never smoked, who might be 
more likely to be exposed to second-hand smoke from 
their husbands in earlier studies than men who never 
smoked) and the reliability of measuring exposure to 
second-hand smoke. Many of the studies started before 
smoke-free laws were implemented. Only one study 
adjusted for second-hand smoke,32 and the reported 
relative risks for coronary heart disease associated 
with one versus 20 cigarettes per day were 1.45 versus 
1.82 in men and 2.03 versus 2.63 in women, in line 
with those from the meta-analyses.
Strengths of study
Strengths of our analyses include that we combined 
data from 55 cohort study reports (which together 
contained 141 separate cohort studies), many of which 
were large. For example, the studies of coronary heart 
disease in men were together based on approximately 
3.07 million participants, including more than 75 000 
cases of coronary heart disease; for stroke, the total 
was approximately 3.53 million men, including at 
least 73 000 cases. Similarly, for women, the combined 
studies contained around 2.56 million participants, 
including at least 36 000 cases of coronary heart 
disease, with corresponding numbers of 3.78 million 
and 62 000 cases in studies of stroke. The meta-
analyses should therefore provide sufficiently reliable 
estimates of relative risks associated with low and 
high cigarette consumption. By using only prospective 
cohort studies, in which smoking consumption is 
recorded before development of cardiovascular 
disease, we avoid biases associated with retrospective 
designs, such as case-control studies. We report results 
separately for three disease groups (coronary heart 
disease, stroke, and cardiovascular disease), each 
according to sex and age. We also did three types of 
statistical analyses. Importantly, results showed 
consistency between men and women, between the 
disease groups, and between the different forms of 
analysis.
Limitations of study
Our analyses also had some limitations. Firstly, we did 
not have individual level data for study participants 
(many studies are old). A few datasets of cardiovascular 
disease and smoking are publicly available, but our 
aim was to be comprehensive and not restrict ourselves 
to having only a few studies. Furthermore, cigarette 
consumption is often recorded in categories (such as 
one to five and six to 10 cigarettes per day), not a specific 
number, so the ability to do regression modelling using 
whole numbers of cigarettes (rather than categories) is 
limited. Also, smokers are not expected to consume 
the same number of cigarettes each day, so using 
categories probably better reflects their intake. Having 
Table 2 | Meta-analyses according to whether studies made allowance for multiple confounding factors
Cohort and analysis* No of studies
From pooling results for 1 and 20 CPD separately across studies From meta-regressions (uses within study analyses)
RR (95% CI) for 1 CPD RR (95% CI) for 20 CPD Excess RR (%)† RR for 1 CPD RR for 20 CPD Excess RR (%)†
Coronary heart disease
Men:
 Adjusted 11 1.74 (1.50 to 2.03) 2.27 (1.90 to 2.72) 58 1.65 2.22 53 (54)
 Unadjusted 15 1.36 (1.18 to 1.56) 1.89 (1.71 to 2.08) 40 1.33 1.91 36 (38)
Women:
 Adjusted 9 2.19 (1.84 to 2.61) 3.95 (3.34 to 4.67) 40 2.12 3.98 38 (34)
 Unadjusted 9 1.26 (1.07 to 1.49) 2.11 (1.91 to 2.34) 23 1.28 2.12 25 (23)
Stroke
Men:
 Adjusted 6 1.30 (1.11 to 1.53) 1.56 (1.31 to 1.86) 54 1.35 1.55 64 (62)
 Unadjusted 11 1.20 (1.07 to 1.35) 1.68 (1.45 to 1.95) 29 1.26 1.68 38 (34)
Women:
 Adjusted 5 1.46 (1.20 to 1.78) 2.42 (1.67 to 3.52) 32 1.50 2.39 36 (33)
 Unadjusted 5 1.15 (0.98 to 1.35) 1.94 (1.44 to 2.61) 16 1.14 1.91 15 (34)
CPD=cigarettes per day; RR=relative risk compared with never smokers.
*Adjusted includes only studies that reported RRs after allowance for ≥3 multiple confounders (which includes cholesterol for coronary heart disease studies and cholesterol or blood pressure for 
stroke studies), plus another study that made multi-factor adjustments.59 Unadjusted includes all other studies (although all allowed for age and occasionally one more factor).
†Percentage excess RR for smoking 1 CPD as percentage of that for 20 CPD. Numbers in parentheses are from same type of analyses as in fig 2 (that is, median value from within study 
comparisons).
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raw data would allow more sophisticated models 
between risk and consumption to be examined (with 
increased power for these analyses), compared with 
using a log-linear regression of summary data (based 
on only several smoking categories). However, our aim 
was to get sufficiently good approximate estimates of 
the excess risks in relation to the primary comparison: 
between the lowest and about 20 cigarettes per day 
group, rather than describe the whole dose-response 
range. As such, our estimates are supported by two 
sources of evidence (several individual studies and a 
potentially more sensitive dose-response model from 
a large study). The first source comprises the effects 
reported in individual studies (supplementary table 
B), showing a consistently high observed relative risk 
of coronary heart disease/stroke at the lowest cigarette 
consumption, relative to the highest consumption 
group, without using a fitted model, 17 29 33 39 50 53 55 57 
63 71 72 which are in line with our modelled estimates. 
The second source comprises the results from one 
of the largest studies (Cancer Prevention Study 
II),10 in which the authors fitted a non-linear model 
between a measure of tobacco smoke (particular 
matter: PM2.5) and the relative risk for cardiovascular 
disease, using their raw data. The model was: relative 
risk=1+(0.2685×PM2.5 dose
0.2730). An inhaled PM2.5 
dose of about 12 mg corresponds to about one cigarette 
per day, which produces a relative risk of 1.53 (both 
sexes combined), reassuringly in between our estimate 
of 1.48 for men and 1.57 for women (coronary heart 
disease) using our simpler log-linear model (and close 
to 1.63 for cardiovascular disease and both sexes 
combined). The relative risk estimate for 20 cigarettes 
per day from the more sophisticated model is 2.20, 
so one cigarette per day represents 44% of the excess 
relative risk ((1.53−1)/(2.20−1)), close to our estimate 
of 50% (cardiovascular disease both sexes; table 1). 
Furthermore, the Cancer Prevention Study II showed 
that there was no low threshold associated with a safe 
level of smoking in relation to cardiovascular disease 
risk, for which even an inhaled PM2.5 dose of 1 mg (one 
twelfth of a cigarette per day) has an expected relative 
risk of 1.25.10
Secondly, methods are available for estimating dose-
response associations for meta-analyses that take into 
account that relative risk estimates across smoking 
categories are expected to be correlated within a study 
because they use the same reference group (never 
smokers in our case). One such method requires 
frequency counts in each exposure group and assumes 
that adjusted relative risks are similar to unadjusted 
ones.88 However, frequency data were not reported for 
many studies, and it is essential to use age adjusted 
relative risks because age is an important confounder 
for cardiovascular disease; and ideally other known 
confounders should also be accounted for. One main 
consequence of using methods such as this is that they 
produce wider 95% confidence intervals, which is 
unlikely to change our conclusions.
Thirdly, we used number of cigarettes per day, which 
is the most commonly reported measure, including in 
high profile studies.55 Although duration of smoking 
is also important when considering risk, it is highly 
correlated with age, which itself is a risk factor, so 
separating their effects can be difficult89; however, large 
studies tend to show a relation between duration and 
risk.89 Because light smoking seems to have dramatic 
effects on cardiovascular disease, shorter duration 
might also be associated with a higher than expected 
risk. This was confirmed in three cohort studies 
that reported duration,38 50 90 and Pope et al 2011 
concluded that the steep association with cigarettes 
per day did not materially change when duration was 
allowed for in the Cancer Prevention Study II study.10 In 
another study,50 the relative risk for less than 10 years’ 
smoking duration was 1.73, compared with 2.51 for 
30-40 years’ duration, representing 48% of the excess 
relative risk (and these relative risks had been adjusted 
for number of cigarettes smoked per day). Similarly, the 
relative risk for smoking one to five cigarettes per day 
was 1.88, representing 40% of the excess relative risk 
for smoking 15-20 cigarettes per day (3.20), and these 
relative risks had been adjusted for duration (years) 
of smoking. Although long duration has persistent 
cumulative effects, a large proportion of the risk seems 
to occur in the short term.91
Fourthly, some heavy smokers could misreport 
as light smokers at baseline (or vice versa, although 
few like this are expected), but if this represented a 
substantial proportion there would probably be non-
linear associations between consumption and the risk 
of other disorders (for example, lung cancer), which 
is generally not seen in large studies.10 17 55 However, 
self reported smoking status has been shown to be 
acceptable, at least in older observational studies.92 
Even if we assumed that misclassification was so 
extreme that it halved the excess risk for coronary heart 
disease for one cigarette per day (from table 1, 24% 
for men where relative risk=1.48 and 29% for women 
where relative risk=1.57), these estimates would 
still be substantially higher than the 5% expected if 
assuming a linear relation with risk.
Supporting biological mechanisms
Substantial biological evidence shows that 
components of cigarette smoke lead to endothelial 
injury, cell dysfunction, atherosclerosis and acute 
thrombosis, and decreased ability of the blood 
to carry oxygen.84 89 Several such studies were 
summarised previously with regards to increased 
platelet aggregation and increased carotid arterial 
wall thickening at low cigarette consumption, 
and coronary heart disease and stroke may have 
common underlying pathways.12 84 Harmful effects 
at low doses are further supported by studies of 
second-hand smoke that show adverse actions 
on subclinical vascular disease and thickening of 
carotid artery walls.89 Barnoya and Glantz describe 
a wide range of potential mechanisms by using a 
comprehensive literature review to purport that 
platelet and endothelial function, arterial stiffness, 
atherosclerosis, oxidative stress, inflammation, heart 
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rate variability, energy metabolism, and increased 
infarct size are all sensitive to second-hand smoke.93 
They also noted that even brief exposure to second-
hand smoke has notable adverse effects on these 
mechanisms, compared with that in active smokers. 
Three recent experimental studies focused on low 
consumption/exposure.94-96 In one study, 29 smokers 
each consumed a single cigarette, immediately after 
which they had a significant decrease in blood vessel 
output power and significant increase in blood 
vessel ageing level and remaining blood volume 25 
minutes later, as markers of atherosclerosis.94 In 
another study, human coronary artery endothelial 
cells were exposed to the smoke equivalent to one 
cigarette, which led to activation of oxidant stress 
sensing transcription factor NFR2 and up-regulation 
of cytochrome p450, considered to have a role in the 
development of heart disease.95 These effects were 
not seen when heart cells were exposed to the vapour 
from one e-cigarette.95 A study exposed adult mice to 
low intensity tobacco smoke (two cigarettes) for one 
to two months and found adverse histopathological 
effects on brain cells.96
Indirect evidence for large harmful effects seen at 
low consumption also comes from studies reporting 
significantly reduced hospital admissions for 
cardiovascular disease shortly after the introduction 
of smoke-free legislation in various countries,97-101 
including systematic reviews.83 102 103 One such 
review, based on 45 studies, showed that the risk 
of hospital admission was reduced by 15% for 
all coronary events and 16% for cerebrovascular 
events.104 The authors reported that the benefit 
remained with longer follow-up after the legislation 
was implemented, and greater risk reductions were 
seen with more comprehensive laws.
Occasional smokers and reduced smoking
Limited data exist on the increase in risk among 
occasional or non-daily smokers. A previous study 
found a 50% increased risk of cardiovascular disease 
mortality among men in Finland who smoked 
occasionally.105 Of those who reported smoking daily or 
occasionally in the Smoking Toolkit Study in England, 
only 2% smoked less than one cigarette per day (“very 
light”),106 but just over 10% smoked on a non-daily 
basis.107 The non-daily smokers in the Smoking Toolkit 
Study smoked on average 5.2 cigarettes a day,107 so 
their risk is probably similar to that reported in our 
review.
In the results section, we outlined three large 
studies that reported little benefit on the risk of 
cardiovascular disease among heavy smokers who 
significantly reduced their consumption (unlike 
the large risk reduction for lung cancer), further 
supportive of a substantial effect of light smoking 
on cardiovascular disease. More evidence exists on 
the beliefs about health and reduced smoking (as 
opposed to quitting), in addition to the large US 
study mentioned in the introduction.9 One survey 
among 12-15 year old students showed that almost 
60% of regular smokers believed that occasional 
smoking carried little or no health risks,108 and in 
another study 60% of e-cigarette users said that the 
reason for using e-cigarettes was to reduce cigarette 
consumption in order to reduce health risks.109 
Even in a recent survey of 1602 people in France 
in 2014-15 (51% were former or current smokers), 
34% thought that smoking up to 10 cigarettes per 
day carried no risk of lung cancer, and only half 
of respondents believed that there was no safe 
cigarette.110 Other surveys indicate that smokers 
perceive harm reduction associated with cigarettes 
marketed as “light” or “low tar,”111-114 even though 
the scientific evidence shows no benefit. Although 
cutting down has clear benefits, particularly for risk 
of cancer, the reduction in cardiovascular disease 
risk is not as large as smokers might expect.
Policy implications and future research
Individual research studies on the effects of light 
smoking have occasionally appeared in the media. 
Examples include “Even a cigarette a day is bad for 
your health” in the New York Times in December 2016 
and the BBC’s “Light smoking doubles sudden death 
risk in women” in December 2012; governmental 
reports have also referred to this question.89 However, 
our paper is the first to combine results across many 
studies covering both coronary heart disease and 
stroke, making it a valuable reference that can be used 
to strengthen public health campaigns (including 
those on smoking cessation services) and to provide a 
strong health incentive for smokers to quit (particularly 
women), rather than cut down. We also hope to raise 
more awareness of the subject among cardiovascular 
health professionals, primary care physicians, and 
smoking cessation specialists.
Heart disease and stroke are common disorders and 
causes of death. In the UK, about 73 000 deaths due 
to coronary heart disease and 41 000 due to stroke 
occur each year (compared with 36 000 for lung 
cancer),115 and this is after the decline in mortality 
over time, mainly due to prevention and better 
treatments. However, the number of deaths is greatly 
over-shadowed by the number of events: more than 
493 000 inpatient hospital episodes for coronary 
heart disease and 236 000 for stroke each year.115 
This means that many more people are living with 
cardiovascular disease, with a major effect on their 
social and physical functioning, as well as time off 
work and use of local health services. The situation is 
similar in the US, with 370 000 deaths from coronary 
heart disease and 140 000 from stroke each year 
(compared with 155 000 for lung cancer), but the 
number of first heart attacks is 525 000 and that of 
first strokes is 610 000.116 117 Fifteen to 20% of all 
cardiovascular disease events might be attributable 
to smoking, representing a substantial number of 
people that require care and treatment, but many 
events are avoidable. Thun et al, using recent US 
cohort study data (beginning 2000-10), indicated 
that given the increasing relative risks for coronary 
RESEARCH
12 doi: 10.1136/bmj.j3984 | BMJ 2018;360:j3984 | the bmj
heart disease over time, about two thirds of the 
coronary heart disease deaths that occur in smokers 
could be attributable to their habit.62
The impact of smoking in places like China is of 
major interest. Although smoking prevalence in China 
has decreased in recent years, the absolute number of 
smokers is high, with an estimated 1 million deaths 
(all causes) due to tobacco in 2010.118 In a nationally 
representative survey in 2010, only 17% of current 
smokers said that they intended to quit, indicating 
that if Chinese smokers follow similar patterns to those 
in Western countries, many active smokers could be 
more inclined to reduce consumption rather than 
quit completely.119 The relatively low overall smoking 
prevalence among all Chinese women (<2%) might 
mask differences between those in rural and urban 
areas, as well as habits in younger women. In a 2008 
survey of girls and women aged 14-24 years at high 
school or college, 4.2% of those in urban areas were 
current smokers, double the 1.9% seen in rural areas; 
and 38% of those surveyed in the urban locations 
did not believe that smoking increases the risk of 
cardiovascular disease (compared with 6% when 
asked about lung cancer).120
Quitting smoking greatly reduces the risk of 
cardiovascular disease, with important benefits gained 
soon after stopping (quicker than for cancer). 52 55 84 
89  121 Smokers can use nicotine containing products 
such as gum, patches, and electronic cigarettes. 
Although e-cigarettes have had much attention, they 
are considered by several experts to be significantly 
safer than cigarettes,122 123 and they are believed to be 
partly responsible for the decline in smoking prevalence 
in the UK,124 findings that are in contrast to the claim 
that e-cigarettes help to maintain smoking rates. 
Therefore, they are an important component of harm 
reduction that can help people to quit completely,4 
84 which is necessary to significantly reduce the risk 
of cardiovascular disease. Although specific adverse 
effects of e-cigarettes on the cardiovascular system 
could be investigated further,125 126 such effects, if they 
exist, are unlikely to be as harmful as the high risk of 
cardiovascular disease associated with light smoking 
that we show here.
Conclusions
Smokers who cut down the number of cigarettes they 
use can benefit from large reductions in the risk of 
cancer and some benefits on cardiovascular disease. 
However, smoking only one to five cigarettes per day 
is associated with a risk of coronary heart disease and 
stroke that is substantially higher than many health 
professionals or smokers recognise (as much as half 
the risk of smoking 20 per day). We show clearly that 
no safe level of smoking exists for cardiovascular 
disease at which light smokers can assume that 
continuing to smoke does not lead to harm. Smokers 
need to quit completely rather than cut down if they 
wish to avoid most of the risk associated with heart 
disease and stroke, two common and major disorders 
caused by smoking.
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